Today: May 28, 2018, 5:33 am
  
Business

Medicortex Finland Oy: Clinical Trial Launched for Detection of Traumatic Brain Injury

PR-Inside.com: 2017-12-28 11:15:02

Medicortex Finland Oy: Clinical Trial Launched for Detection of Traumatic Brain Injury

Medicortex Finland Oy
Dr. Adrian Harel - CEO
Tel. +358 (0) 400 488 817
adrian.harel@medicortex.fi
http://www.medicortex.fi

Medicortex Finland Oy today announced that the first patient has been enrolled in the Phase 2 clinical trial of ProbTBI™ diagnostic kit for Traumatic Brain Injury (TBI) detection. Further recruitments will be made in the central hospitals of Turku and Pori in Finland during the next few months.

The trial is conducted at two leading TBI clinical sites in Finland and it is expected to enroll up to 160 study subjects, most of them trauma patients with head injury or with bone fractures, but also healthy control subjects. The three subgroups of the population are selected to produce the best result of the study. The primary outcome measure will be determination of the biomarker levels in the study groups. People can follow the status and progression of the study in the clinical trials database in which the trial is posted under identifier NCT03306563 (www.clinicals.gov).

"ProbTBI is a highly innovative and advanced diagnostic kit for rapid detection of TBI, and now it is further developed in this second trial" said Dr. Adrian Harel, CEO of Medicortex.

Dr. Mårten Kvist, Medical Director of Medicortex says: "Medicortex plans to quickly advance its second clinical trial to confirm the promising findings of its previous proof-of-concept study. Such a diagnostic tool is truly awaited and it will considerably improve the possibilities to detect a traumatic brain injury in patients who are suffering from symptoms caused by a hit to the head.”

Medicortex Finland Oy is a biotechnology company engaged in the development of first-of-its-kind diagnostic kit for rapid detection of concussion and mild TBI. The Company has the technology to capture biomarkers from body fluid samples and to develop them into useful diagnostic tools. The patent portfolio grants a secure background to develop its innovative diagnostic kit. More information about TBI and its detection is available on Company's website at www.medicortex.fi. Investors are welcomed to join and support development of the diagnostic kit, information available at www.medicortex.fi/investors.

About Medicortex

Medicortex Finland Oy is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Its current focus is on developing biomarker diagnostics to detect the presence and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt the progression of brain injury.

Key words: brain injury, head injury, concussion, diagnostics, TBI, early detection, military, army, soldier, trauma, PTSD, clinical trial

Press Information


Published by
Hossam Abdel-Kader
+43 1 9582319
e-mail
www.pr-inside.com/



# 632 Words
Related Articles
More From The Author
Neste Corporation - Notification of Managers' Transactions, [..]
Neste CorporationManagers' Transactions 28 December 2017 at 12 am (EET) Neste Corporation - Notification of Managers' Transactions, [..]
Gazit Brasil Acquires 70% of One of [..]
TEL-AVIV, Israel and SAO PAULO, Brazil, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Gazit-Globe (NYSE:GZT) (TSX:GZT) (TASE:GZT), a global [..]
Odfjell SE: Financial calendar
FINANCIAL YEAR 2017 15.02.2018 - Quarterly report - Q4 FINANCIAL YEAR 2018 08.05.2018 - Quarterly report - Q1 24.08.2018 - [..]
Huhtamaki to further improve its competitiveness in [..]
HUHTAMÄKI OYJ PRESS RELEASE 28.12.2017 AT 9:00 Huhtamaki to further improve its competitiveness in China Huhtamaki has completed [..]
For 2 Days Only, January 6th to [..]
As part of the Yume (no) Sora Holdings group of companies which promotes creators across genres and national borders, Toranoana [..]
 
More From Business
Tarps Now® Announces Expanded Offers of Sun [..]
ST. JOSEPH, MICHIGAN, UNITED STATES -- Tarps Now® has released a greatly expanded line of outdoor Mesh Sun Shade Tarps [..]
G2H2 Capital Makes a Purchase on the [..]
HONG KONG, May 24, 2018 - (ACN Newswire) - G2H2 Capital ("G2H2") signed an agreement with AnApp Blockchain Technologies Limited [..]
Oppenheimer Europe CEO Max Lami On Course [..]
Oppenheimer Europe CEO Max Lami On Course With M&A Business Expansion Plan, Four Years On Nearly four years have passed [..]
AnApp announces the birth of an innovative [..]
HONG KONG, May 21, 2018 - (ACN Newswire) - AnApp Blockchain Technologies Limited ("AnApp") announces the development of [..]
HKTDC Entrepreneur Day 2018 Opens
Most International and Tech-focused Edition Ever HONG KONG, May 17, 2018 - (ACN Newswire) - A record 276 exhibitors are [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.